Merit Oncology is the oncology-focused brand of Merit Medical Systems, a medical-device manufacturer founded in 1987. Merit Medical develops and markets disposable devices for interventional, diagnostic and therapeutic procedures, serving hospitals and physicians worldwide. The wider company employs approximately 7,300 people globally. Merit Oncology focuses on precision localization technology intended to support care from breast lesion diagnosis through surgery.

Its featured products include SCOUT and SCOUT MD, wire-free localization platforms using RADAR technology to detect and guide clinicians to targeted lesions. SCOUT is designed to allow a reflector to be placed during biopsy, potentially eliminating a separate localization appointment. The company describes the system as non-magnetic and non-radioactive, compatible with pre-operative MRI, and designed to remain stable between placement and surgery. SCOUT MD applies refined RADAR technology to surgical localization.

Merit Oncology provides product information and educational resources for healthcare professionals, along with patient-focused explanations of the technology and its role in treatment.